Form 4 for AQST Aquestive Therapeutics, Inc.
Accepted 2026-09-16 14:00:36 ET · period of report 2026-09-15 · accession 0001214659-26-011731 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-16 14:00 | 2026-09-15 | AQST | Barber Daniel | Pres, CEO, Dir | S - Sale | $4.82 | -25.0K | 652.3K | -4% | -$120.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-15 | S | D | 25,000 | $4.82 | 652,317 | D | — | — | (F1) The reported transaction involves sale transactions from $4.78 to $4.90 per share. The weighted average price per share was $4.8195. The Reporting Person undertakes to provide upon request by the SEC staff, the Issuer or a security holder of the Issuer, information regarding the number of shares sold at each separate price. |